Literature DB >> 1861216

Nationwide survey of Kawasaki disease and acute rheumatic fever.

K A Taubert1, A H Rowley, S T Shulman.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1861216     DOI： 10.1016/s0022-3476(05)80742-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  64 in total

1.  Recognition and management of Kawasaki disease.

Authors:  R K Han; B Sinclair; A Newman; E D Silverman; G W Taylor; P Walsh; B W McCrindle
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

2.  Atypical Kawasaki disease--a clinical challenge.

Authors:  Jonathan Forsey; Luc Mertens
Journal:  Eur J Pediatr       Date:  2011-11-25       Impact factor: 3.183

3.  Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: A case report.

Authors:  Timothy Ronan Leahy; Eyal Cohen; Upton D Allen
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 4.  The clinical efficacy of IVGG in Kawasaki disease.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

5.  Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation.

Authors:  Mark Gorelik; David C Wilson; Yona K Cloonan; Stanford T Shulman; Raphael Hirsch
Journal:  J Pediatr       Date:  2012-02-07       Impact factor: 4.406

6.  Evaluation of left ventricular systolic strain in children with Kawasaki disease.

Authors:  Qiu-Qin Xu; Yue-Yue Ding; Hai-Tao Lv; Wan-Ping Zhou; Ling Sun; Jie Huang; Wen-Hua Yan
Journal:  Pediatr Cardiol       Date:  2014-05-25       Impact factor: 1.655

7.  Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.

Authors:  S A Cameron; S M White; D Arrollo; S T Shulman; A H Rowley
Journal:  Clin Exp Immunol       Date:  2017-08-07       Impact factor: 4.330

Review 8.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

9.  Recognizing Kawasaki disease.

Authors:  B Lang
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

10.  Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease.

Authors:  A C Lau; T T Duong; S Ito; G J Wilson; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.